Stones from bowel disease

Endocrinology and Metabolism Clinics of North America

Volumn 31, Issue 4, 2002, Pages 979-999

  Worcester, Elaine M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALI; BICARBONATE; CALCIUM OXIDE; CITRATE POTASSIUM; CITRIC ACID; FATTY ACID; LAXATIVE; MAGNESIUM; OXALIC ACID; POTASSIUM; URIC ACID; WATER; CALCIUM OXALATE;

CALCIUM STONE; COLITIS; CRYSTALLIZATION; DIARRHEA; DIET THERAPY; ENTEROPATHY; HUMAN; HYPEROXALURIA; ILEOSTOMY; NEPHROLITHIASIS; PRIORITY JOURNAL; REVIEW; SMALL INTESTINE RESECTION; STEATORRHEA; TOTAL COLON RESECTION; URIC ACID STONE; URINE PH; URINE VOLUME; CROHN DISEASE; FEMALE; MALE; METABOLISM; PH; SOLUBILITY; ULCERATIVE COLITIS; URINE;

CALCIUM OXALATE; COLITIS, ULCERATIVE; CROHN DISEASE; CRYSTALLIZATION; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; KIDNEY CALCULI; MALE; SOLUBILITY; URIC ACID;

EID: 0036894239     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(02)00035-X     Document Type: Review

References (75)

1. Deren JJ, Porush JG, Levitt MF, et al. Nephrolithiasis as a complication of ulcerative colitis and regional enteritis. Ann Int Med 1962;56:843-53.
2. Gelzayd EA, Breuer RI, Kirsner JB. Nephrolithiasis in inflammatory bowel disease. Am J Digest Dis 1968;13:1027-34.
3. Knudsen L, Marcussen H, Fleckenstein P, et al. Urolithiasis in chronic inflammatory bowel disease. Scand J Gastroent 1978;13:433-6.
4. Bambach CP, Robertson WG, Peacock M, et al. Effect of intestinal surgery on the risk of urinary stone formation. Gut 1981;22:257-63.
5. Fukushima T, Ishiguro N, Matsuda Y, et al. Clinical and urinary characteristics of urolithiasis in ulcerative colitis. Am J Gastroenterol 1982;77:238-42.
6. Fukushima T, Yamazaki Y, Sugita A, et al. Prophylaxis of uric acid stone in patients with inflammatory bowel disease following extensive colonic resection, Gastroenterol Japonica 1991;26:430-4.
7. Clarke AM, McKenzie RG. Ileostomy and the risk of urinary uric acid stones. Lancet 1969;2:395-7.
8. Kennedy HJ, Al-Dujaili EAS, Edwards CRW, et al. Water and electrolyte balance in subjects with a permanent ileostomy. Gut 1983;24:702-5.
9. Hill GL, Goligher JC, Smith AH, et al. Long term changes in total body water, total exchangeable sodium and total body potassium before and after ileostomy. Br J Surg 1975;62:524-7.
10. Christie PM, Knight GS, Hill GL. Comparison of relative risks of urinary stone formation after surgery for ulcerative colitis: Conventional ileostomy vs J-pouch. Dis Colon Rectum 1996;39:50-4.
11. Stelzner M, Phillips JD, Saleh S, et al. Nephrolithiasis and urine ion changes in ulcerative colitis patients undergoing colectomy and endorectal ileal pullthrough. J Surg Res 1990;48:552-6.
12. Reisner GS, Wilansky DL, Schneiderman C. Uric acid lithiasis in the ileostomy patient. Br J Urol 1973;45:340-3.
13. Caudarella R, Rizzoli E, Pironi L, et al. Renal stone formation in patients with inflammatory bowel disease. Scanning Microsc 1993;7:371-80.
14. Buchman AL, Moukarzel AA, Ament ME. Excessive urinary oxalate excretion occurs in long-term TPN patients both with and without ileostomies. J Am Coll Nutr 1995;14:24-8.
15. Galland L. Magnesium and inflammatory bowel disease. Magnesium 1988;7:78-83.
16. Rudman D, Dedonis JL, Fountain MT, et al. Hypocitraturia in patients with gastro-intestinal malabsorption. N Engl J Med 1980;303:657-61.
17. Pak CYC, Fuller C, Sakhaee K, et al. Long-term treatment of calcium nephrolithiasis with potassium citrate. J Urol 1985;134:11-9.
18. Hessov I, Hasselblad C, Fasth S, et al. Magnesium deficiency after ileal resections for Crohn's disease. Scand J Gastroenterol 1983;18:643-9.
19. Hylander E, Ladefoged K, Jarnum S. Calcium absorption after intestinal resection. Scand J Gastroent 1990;25:705-10.
20. Smith LH, Hofman AF, McCall JT, et al. Secondary hyperoxaluria in patients with ileal resection and oxalate nephrolithiasis. Clin Res 1970;18:541.
21. Admirand WH, Earnest DL, Williams HE. Hyperoxaluria and bowel disease. Trans Assoc Am Physicians 1971;84:307-12.
22. Dowling RH, Rose GA, Sutor DJ. Hyperoxaluria and renal calculi in ileal disease. Lancet 1971;1:1103-6.
23. Ogilvie D, McCollum JPK, Packer S, et al, Urinary outputs of oxalate, calcium, and magnesium in children with intestinal disorders. Arch Dis Child 1976;51:790-5.
24. Barilla DE, Notz C, Kennedy D, et al. Renal oxalate excretion following oral oxalate loads in patients with ileal disease and with renal and absorptive hypercalciurias. Am J Med 1978;64:579-85.
25. Caspary WF, Tonissen J, Lankisch PG. 'Enteral' hyperoxaluria: Effect of cholestyramine, calcium, neomycin, and bile acids on intestinal oxalate absorption in man. Acta Hepato-Gastroenterol 1977;24:193-200.
26. Earnest DL, Johnson G, Williams HE, et al. Hyperoxaluria in patients with ileal resection: An abnormality in dietary oxalate absorption. Gastroenterology 1974;66:1114-22.
27. Lindsjo M, Danielson BG, Fellstrom B, et al. Intestinal oxalate and calcium absorption in recurrent renal stone formers and healthy subjects. Scand J Urol Nephrol 1989;23:55-9.
28. Chadwick VS, Modha K, Dowling RH. Mechanism for hyperoxaluria in patients with ileal dysfunction. N Engl J Med 1973;289:172-6.
29. Stauffer JQ, Humphreys MH, Weir GJ. Acquired hyperoxaluria with regional enteritis after ileal resection. Annals Int Med 1973;79:383-91.
30. Marangella M, Petrarulo M, Vitale C, et al. Plasma and urine glycolate assays for differentiating the hyperoxaluria syndromes. J Urol 1992;148:986-9.
31. Walker VR, Sutton RAL. Calcium supplementation for enteric hyperoxaluria secondary to intestinal bypass. In: Ryall R, Bais R, Marshall VR, et al, editors. Urolithiasis 2. New York: Plenum Press; 1994. p. 557-61.
32. Hylander E, Jarnum S, Frandsen I. Urolithiasis and hyperoxaluria in chronic inflammatory bowel disease. Scand J Gastroent 1979;14:475-9.
33. Andersson H, Jagenburg R. Fat-reduced diet in the treatment of hyperoxaluria in patients with ileopathy. Gut 1974;15:360-6.
34. Dobbins JW, Binder HJ. Importance of the colon in enteric hyperoxaluria. N Engl J Med 1977;296:298-301.
35. McDonald GB, Earnest DL, Admirand WH. Hyperoxaluria correlates with fat malabsorption in patients with sprue. Gut 1977;18:561-6.
36. Modigliani R, LaBayle D, Aymes C, et al. Evidence for excessive absorption of oxalate by the colon in enteric hyperoxaluria. Scand J Gastroent 1978;13:187-92.
37. Stauffer JQ. Hyperoxaluria and intestinal disease: The role of steatorrhea and dietary calcium in regulating intestinal oxalate absorption. Digest Dis 1977;22:921-8.
38. Hocking MP, Duerson MC, O'Leary JP, et al. Jejunoileal bypass for morbid obesity. N Engl J Med 1983;308:995-9.
39. Gregory JG, Starkloff EB, Miyai K, et al. Urologic complications of ileal bypass operation for morbid obesity. J Urol 1975;113:521-4.
40. Gregory JG, Park IY, Schoenberg HW. Oxalate stone disease after intestinal resection. J Urol 1977;117:631-4.
41. Lindsjo M, Danielson BG, Fellstrom B, et al. Intestinal absorption of oxalate and calcium in patients with jejunoileal bypass. Scand J Urol Nephrol 1989;23:283-9.
42. Binder HJ. Intestinal oxalate absorption. Gastroenterology 1974;67:441-6.
43. Saunders DR, Sillery J, McDonald GB. Regional differences in oxalate absorption by rat intestine: Evidence for excessive absorption by the colon in steatorrhea. Gut 1975;16:543-54.
44. Kathpalia SC, Favus MJ, Coe FL. Evidence for size and charge permselectivity of rat ascending colon. Effects of ricinoleate and bile salts on oxalic acid and neutral sugar transport. J Clin Invest 1984;74:805-11.
45. Knickelbein RG, Aronson PS, Dobbins JW. Oxalate transport by anion exchange across rabbit ileal brush border. J Clin Invest 1986;77:170-5.
46. Hatch M, Freel RW, Vaziri ND. Mechanisms of oxalate absorption and secretion across the rabbit distal colon. Pflugers Arch 1994;426:101-9.
47. Hatch M, Vaziri N. Segmental differences in intestinal oxalate transport. FASEB J 1991;5:A1138.
48. Hofmann AF, Poley JR. Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. Gastroenterology 1972;62:918-34.
49. Dobbins JW, Binder HJ. Effect of bile salts and fatty acids on the colonic absorption of oxalate. Gastroenterology 1976;70:1096-100.
50. Fairclough PD, Feest TG, Chadwick VS, et al. Effect of sodium chenodeoxycholate on oxalate absorption from the excluded human colon - A mechanism for 'enteric' hyperoxaluria. Gut 1977;18:240-4.
51. Earnest DL, Gancher S, Admirand WH. Treatment of enteric hyperoxaluria (EHO) with calcium and aluminum. Gastroenterology 1976;70:881.
52. Earnest DL, Williams HE, Admirand WH. Treatment of enteric hyperoxaluria with calcium and medium chain triglyceride (MCT), Clin Res 1975;23:130A.
53. Allison MJ, Cook HM, Milne DB, et al. Oxalate degradation by gastrointestinal bacteria from humans. J Nutr 1986;116:455-60.
54. Argenzio RA, Liacos JA, Allison MJ. Intestinal oxalate-degrading bacteria reduce oxalate absorption and toxicity in guinea pigs. J Nutr 1988;228:787-92.
55. Smith LH. Hyperoxaluric states. In: Coe FL, Favus MJ, editors. Disorders of Bone and Mineral Metabolism. New York: Raven Press; 1992. p, 707-27.
56. Coe FL, Parks JH. Hyperoxaluric states. Nephrolithiasis: Pathogenesis and Treatment, 2nd Edition. Chicago: Yearbook Medical Publishers Inc.; 1988. p, 172-204.
57. Obialo CI, Clayman RV, Matts JP, et al. Pathogenesis of nephrolithiasis post-partial ileal bypass surgery: case-control study, Kidney Int 1991;39:1249-54.
58. Kaye MC, Streem SB, Hall PM. Enteric hyperoxaluria associated with external biliary drainage. J Urol 1994;151:396-7.
59. Brinkley LJ, Gregory J, Pak CYC. A further study of oxalate bioavailability in foods. J Urol 1990;144:94-6.
60. Massey LK, Roman-Smith H, Sutton RA. Effect of dietary oxalate and calcium on urinary oxalate and risk of formation of CaOx kidney stones. J Am Diet Assoc 1993;93:901-06.
61. Hofmann AF, Poley JR. Cholestyramine treatment of diarrhea associated with ileal resection. N Engl J Med 1969;281:397-402.
62. Smith LH, Fromm H, Hofmann AF. Acquired hyperoxaluria, nephrolithiasis, and intestinal disease. N Engl J Med 1972;286:1371-5.
63. Nordenvall B, Backman L, Larsson L, et al. Effects of calcium, aluminium, magnesium and cholestyramine on hyperoxaluria in patients with jejunoileal bypass. Acta Chir Scand 1983;149:93-8.
64. Pak CYC. Hyperoxaluric calcium nephrolithiasis. In: Resnick MI, Pak CYC, editors, Urolithiasis: A Medical and Surgical Reference. Philadelphia: W. B. Saunders Company; 1990. p. 65-77.
65. Nolan CR, Califano JR, Butzín CA. Influence of calcium acetate or calcium citrate on intestinal aluminum absorption, Kidney Int 1990;38:937-41.
66. Lindsjo M, Fellstrom B, Ljunghall S, et al. Treatment of enteric hyperoxaluria with calcium-containing organic marine hydrocolloid. Lancet 1989;2:701-3.
67. Gregory JG. Hyperoxaluria and stone disease in the gastrointestinal bypass patient. Urol Clin North Am 1981;8:331-51.
68. Salvatierra Jr. O, Longaker M, Crombleholme T. Bilateral renal autotransplantation with pyelovesicostomy: A surgical treatment of refractory enteric hyperoxaluria. Surgery 1989;105:430-5.
69. Renda SA, Pichette V, Nolin L, et al. Ammonium acid urate urolithiasis. J Urol 1993;149:252A.
70. Dick WH, Lingeman JE, Preminger GM, et al. Laxative abuse as a cause for ammonium urate renal calculi. J Urol 1990;143:244-7.
71. Dick WH, Smith LH, Wilson DM, et al. The clinical spectrum of ammonium urate renal calculi, In: Ryall R, Bais R, Marshall VR, et al, editors. Urolithiasis 2. New York: Plenum Press; 1994, p. 567-70.
72. Teotia M, Sutor DJ. Crystallisation of ammonium acid urate and other uric acid derivatives from urine. Br J Urol 1971;43:381-6.
73. Bowyer RC, McCulloch RK, Brockis JG, et al. Factors affecting the solubility of ammonium acid urate. Clin Chem Acta 1979;95:17-22.
74. Battle DC, von Riotte A, Schlueter W. Urinary sodium in the evaluation of hyperchloremic metabolic acidosis. N Engl J Med 1987;316:140-4.
75. Richardson RMA, Halperin ML. The urine pH: A potentially misleading diagnostic test in patients with hyperchloremic metabolic acidosis. Am J Kidney Dis 1987;10:140-3.